{
    "1650424396396257280": {
        "attachments": {
            "media_keys": [
                "13_1650424345464909826"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-04-24T09:00:14.000Z",
        "edit_history_tweet_ids": [
            "1650424396396257280"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 146,
                    "normalized_text": "SevereAsthma",
                    "probability": 0.5654,
                    "start": 135,
                    "type": "Other"
                },
                {
                    "end": 178,
                    "normalized_text": "OCS",
                    "probability": 0.5228,
                    "start": 176,
                    "type": "Other"
                },
                {
                    "end": 215,
                    "normalized_text": "OCS",
                    "probability": 0.5268,
                    "start": 213,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 147,
                    "start": 134,
                    "tag": "SevereAsthma"
                }
            ],
            "urls": [
                {
                    "display_url": "spr.ly/6014OuBw4",
                    "end": 272,
                    "expanded_url": "http://spr.ly/6014OuBw4",
                    "start": 249,
                    "status": 200,
                    "unwound_url": "https://www.astrazeneca.com/media-centre/articles/2023/ocs-severe-asthma-care-time-end-reliance.html?utm_source=twitter&utm_medium=world+asthma+day+2023&utm_term=11877&utm_content=r%26i",
                    "url": "https://t.co/BH83sdZpnQ"
                },
                {
                    "display_url": "pic.twitter.com/qeV5jynV1u",
                    "end": 296,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1650424396396257280/video/1",
                    "media_key": "13_1650424345464909826",
                    "start": 273,
                    "url": "https://t.co/qeV5jynV1u"
                }
            ]
        },
        "id": "1650424396396257280",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 6098,
            "like_count": 15,
            "quote_count": 2,
            "reply_count": 4,
            "retweet_count": 3
        },
        "text": "The increased risk of adverse effects from frequent oral corticosteroid (OCS) use is often underestimated. Our goal is to ensure that #SevereAsthma patients are not reliant on OCS and instead, have more access to OCS-sparing options where possible. https://t.co/BH83sdZpnQ https://t.co/qeV5jynV1u"
    }
}